Patients selecting mechanical heart valve replacements are typically required to monitor their INR levels (international normalized ratio) to prevent risks of blood clotting, haemorrhage or stroke.To ease this process, home INR testing machines are now becoming more affordable and easy-to-use.
qLabs Hand-Held ElectroMeter with Wireless Technology for Professional Point of Care and Patient Self-Testing The qLabs ElectroMeter system is composed of a hand-held unit and disposable strips. The advanced biosensor technology of the qLabs platform enables blood rapid testing by patient-side, so that health care professionals and patients themselves can access real-time, lab-quality results within minutes, right at Point-of-Care or at home, without affecting patient lifestyle. With thousands of users worldwide, the qLabs INR Meter is the most promising Hand-Device device today to monitor Anti-Coagulation for patients be it beside or home!! qLabs Electrometer is Lightweight, portable, compact and easy to use and features:
Current Tests Available for the qLabs ElectroMeter
What are bleeding disorders?
In people with bleeding disorders, the blood clotting process doesn’t work properly. As a result, people with bleeding disorders can bleed for longer than normal, and some may experience spontaneous bleeding into joints, muscles, or other parts of their bodies.
Hemophilia is a bleeding disorder that affects approximately 1 in 10,000 people. People with hemophilia do not have enough clotting factor VIII or IX in their blood. As a result, they can bleed for longer than normal.
The most common bleeding disorder is von Willebrand disease (VWD). It is generally less severe than other bleeding disorders. Many people with VWD may not know that they have the disorder because their bleeding symptoms are very mild.
Rare clotting factor deficiencies are disorders in which one of several clotting factors is missing or not working properly. Less is known about these disorders because they are diagnosed so rarely. In fact, many have only been discovered in the last 40 years.
Finally, inherited platelet disorders are conditions in which platelets don’t work the way they should, resulting in a tendency to bleed or bruise.
What is hemophilia?
Hemophilia is a bleeding problem. People with hemophilia do not bleed any faster than normal, but they can bleed for a longer time. Their blood does not have enough clotting factor. Clotting factor is a protein in blood that controls bleeding.
Hemophilia is quite rare. About 1 in 10,000 people are born with it.
Types of hemophilia
The most common type of hemophilia is called hemophilia A. This means the person does not have enough clotting factor VIII (factor eight).
Hemophilia B is less common. A person with hemophilia B does not have enough factor IX (factor nine). The result is the same for people with hemophilia A and B; that is, they bleed for a longer time than normal.
People are born with hemophilia. They cannot catch it from someone like a cold.
Hemophilia is usually inherited, meaning that it is passed on through a parent’s genes. Genes carry messages about the way the body’s cells will develop as a baby grows into an adult. They determine a person’s hair and eye colour, for example.
Sometimes hemophilia can occur when there is no family history of it. This is called sporadichemophilia. About 30% of people with hemophilia did not get it through their parent’s genes. It was caused by a change in the person’s own genes.
In rare cases, a person can develop hemophilia later in life. The majority of cases involve middle-aged or elderly people, or young women who have recently given birth or are in the later stages of pregnancy. This condition often resolves with appropriate treatment.
The severity describes how serious a problem is. The level of severity depends on the amount of clotting factor that is missing from a person’s blood.
| Level | Percentage of normal factor activity in blood | Number of international units (IU) per millilitre (ml) of whole blood |
| normal range | 50%-150% | 0.50–1.5 IU |
| mild hemophilia | 5%-40% | 0.05–0.40 IU |
| moderate hemophilia | 1%-5% | 0.01–0.05 IU |
| severe hemophilia | less than 1% | less than 0.01 IU |
The signs of hemophilia A and B are the same:
Symptoms
The Q2 Plus Meter from MicroPoint Technologies allows the doctor to perform a simple APTT test with a finger prick.The activated partial thromboplastin time (APTT)is used as a general screening test for the detection of coagulation abnormalities in the intrinsic pathway. The APTTis sensitive to deficiencies or abnormalities of factors VIII,IX,XI,XII,X and II,prekallikrein,high molecular weight kininogen(HMWK),and fibrinogen. If the patient is suffering from Hemophilia disorder the APTT results are higher than normal thus helping the Health Care Provider with instant information with APTT screening results. The abnormal results however can further be confirmed by performing a Lab investigation specific for any deficiency including Factor VIII or IX.
The q2 Plus is available for Professional Point of Care Testing for screening of Hemophilia (Baseline APTT Test Result) with instant results. The q2 Plus docks with e-Station for easy data uploading and hard copy printouts. The devise is also equipped with inbuilt barcode scanning for Patient ID or Test Barcode info capture.
This product is exclusively marketed by Operon Biotech & Health Care headquarted At Bangalore in India.
For further information or for any queries please contact 819-715-5556,984-508-8171,990-014-9100
Email : info@localhost , Web : www.operonbiotech.com
Source:
Hemophilia Society (India)
Global Hemophilia Federation
A PT/INR test helps ensure the effectiveness of the anticoagulant drug warfarin (Coumadin®) and that prothrombin time and internationally normalized ratio is appropriately prolonged. PT-INR tests measure the blood’s ability to clot. Blood normally clots to slow down it’s flow in response to the damage of blood vessels, in order to prevent excessive bleeding. A clot formed inappropriately in the areas of heart, lung and brain, however, can hinder normal blood flow and may result in life-threatening events such as stroke and heart attack. For patients who lose their ability to properly reabsorb clots and patients who have low tolerance to clots, anticoagulation medicine (blood thinner) is prescribed. Because these medications may have narrow therapeutic windows and be sensitive to diet and lifestyle, it may be necessary for patients to adjust their dosage regularly. In order to make good decisions regarding the need for such an adjustment, it is important for the patient to know the clotting status of their blood. PT or INR value from the PT-INR tests helps patients or healthcare professionals make these decisions. A quick and accurate measurement of PT or INR value is critical for the safety and effectiveness of the anticoagulation therapy. The clotting capacity of the blood is reported as a Prothrombin Time (PT) or an International Normalized Ratio (INR) value. qLabs® PT-INR Test Strips While PT times may vary depending on the test method used, INR values should be the same regardless of the method used. International Normalized Ratio (INR) is recommended by WHO to remove dependence on reagent and test method. The qLabs® ElectroMeter calculates the PT value based on an analysis of the test data, and then converts this to the correct INR value.
The qLabs PT/INR test is an easy-to-use finger-stick blood test, designed for professional or home use, that provides highly accurate results within 2 minutes. The dry reagent strips can be stored at room temperature for immediate use for up to 18 months, with no equilibration required.
The APTT test is used primarily to investigate unexplained clotting or bleeding. The qLabs APTT test is an easy-to-use finger-stick blood test, designed for professional use, that provides highly accurate results within 7 minutes. The dry reagent strips can be stored at room temperature for immediate use for up to 18 months, with no equilibration required. The APTT is a general coagulation test used for screening and measuring the functionality of the intrinsic coagulation pathway, which involves the coagulation factor XII, XI, IX, VIII, X, V, II and fibrinogen. It is also used to monitor the effectiveness of heparin therapy. The APTT is a modification of the Partial Thromboplastin Time (PTT); it can provide a more precise and sensitive assay. qLabs® APTT Test Strips The qLabs® APTT test strip measures the blood’s ability to clot which determines the Activated Partial Thromboplastin Time (APTT) on whole blood.
For more details contact us at 8197155556 and 9845088171
We have always been about delivering meaningful and practical solutions in the fields of IVD/POC and HealthCare. We also are better known to offer such solutions in field of Coagulation.
Our product line in coagulation includes several models in Semi Automation & Fully Automation. The MC-1 Micro : A single channel coagulation system from Merlin medicals, GMBH works on the Gold Standard Ball Method Technology most suitable for Low end labs. The XL-1000i is a trendsetter in entry level automation and serves as an ideal replacement for an 4 Channel Semi Automated Systems. The XL-3200 series caters to high throughput labs.
We are different because we can address the specific needs of customers. We listen carefully to the requirements of our clients and then work closely with them for an win-win solutions. Backed with excellent service/tech support, the end result of this positive partnership is not difficult for one to imagine.
Our coagulation systems are backed with world class “QuikCoag” reagents from Biomedica diagnostics inc, Canada. Biomedica Diagnostics is a global manufacturer of Hemostasis Reagents based out of Windsor, Nova Scotia. It develops reagents/diagnostic assays in area of its expertise in Hemostasis/Thrombosis. Be it routine or speciality reagents, count on Biomedica…. Count on Operon…
We believe in “Continuous Improvements” and surprise our customers with latest in innovations in coagulation.
Micropoint bioscience HQ in Santa Clara, California with an GMP ISO 13485 Certified Mfg facility in US and ASIA is a global provider of rapid, accurate poc systems. The qLabs electrometer is a handheld system with disposable test strips using advance biosensor technology enabling two important coagulation tests with just a finger prick:
The test strips are individually foil packed with longer shelf life. The advance technology used in qLabs makes the product highly precise. qLabs reports generates lab quality reports and just in about 2~7 minutes with 10ul of Whole Blood.
It also boasts of wireless communications for smooth data transfer and helps you with a hard copy prints, thanks to the docking E-Station designed especially for qLabs electrometer.
It’s Bluetooth enabled and supports barcode reading.
We have been associated with Operon Biotech and Healthcare for past 7 years. Their products and Services are highly dependable especially in the field of Coagulation
Kims hospital is located in heart of the city with over 800+ beds and with continuous flow in patients, Service becomes a prime factor when we decide a vendor. Am glad to say that Operon Biotech is MOST reliable when it comes to service support and supplies.
Ours is a NABL Certified Laboratory and we choose vendors who are dependable so as to maintain our standards of quality and intime reporting. Operon Biotech and HealthCare offers state-of-the art products and are truly dependable let be supplies or service
The Best Working atmosphere and friendly Environment where We have got so much freedom to work and explore.
Good service
Good company which provides quality equipment’s for healthcare & diagnostics
